Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(10%)
Results Posted
29%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
8
80%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

completed770%
recruiting110%
unknown110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10